STERIS Aktie
242,40USD | -2,73USD | -1,11% |
WKN DE: A2PGLV / ISIN: IE00BFY8C754
Personal
2021 | 2022 | 2023 | 2024 | 2025 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 12 770 | 16 422 | 17 000 | 18 179 | 17 787 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,24 | 0,28 | 0,29 | 0,28 | 0,31 |
Bilanz (in Mio. USD) - Aktiva
2021 | 2022 | 2023 | 2024 | 2025 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 1 212 | 1 879 | 2 011 | 2 869 | 2 001 |
Summe Anlagevermögen | 5 363 | 9 545 | 8 810 | 8 195 | 8 146 |
Summe Aktiva | 6 574 | 11 424 | 10 822 | 11 064 | 10 147 |
Bilanz (in Mio. USD) - Passiva
2021 | 2022 | 2023 | 2024 | 2025 | |
---|---|---|---|---|---|
Summe Fremdkapital | 2 683 | 4 879 | 4 735 | 4 748 | 3 531 |
Summe Eigenkapital | 3 891 | 6 545 | 6 087 | 6 315 | 6 616 |
Summe Passiva | 6 574 | 11 424 | 10 822 | 11 064 | 10 147 |
Adresse
70 Sir John Rogerson's Quay, 2 Dublin | |
Internet | http://www.steris.com |
Management
Bill Brodbeck
Vice President-Regulatory Affairs |
Cary L. Majors
Senior Vice President & President-Healthcare |
Christopher S. Holland
Independent Director |
Cynthia L. Feldmann
Independent Director |
Daniel A. Carestio
President, Chief Executive Officer & Director |
Esther M. Alegria
Independent Director |
Jacqueline B. Kosecoff
Independent Director |
John Adam Zangerle
Secretary, Senior Vice President & General Counsel |
Julie Winter
VP-Investor Relations & Corporate Communications |
Karen Louise Burton
Chief Accounting Officer & Vice President |
Laura Weien
Vice President & Chief Compliance Officer |
Mary Clare Fraser
Chief Human Resources Officer & Senior VP |
Michael Joseph Tokich
Chief Financial Officer & Senior Vice President |
Mohsen M. Sohi
Chairman |
Nirav R. Shah
Independent Director |
Paul E. Martin
Independent Director |
Renato G. Tamaro
Treasurer & Vice President |
Richard Carroll Breeden
Independent Director |
Richard Martin Steeves
Independent Director |
Walter M. Rosebrough
Chief Executive Officer-Emeritus |